Spire Q3 Earnings Call Highlights

SR reported an adjusted loss from continuing operations of $15 million, or $0.26/share, in fiscal Q3 versus an adjusted loss of $13 million, or $0.29/share a year earlier. The results come after divestitures that shifted the company to a fully regulated utility business profile. Overall, losses narrowed on a per-share basis, but the company still reported an adjusted loss.

Analysis

The main market mechanism is not the reported loss itself; it is the quality shift in the asset base. Moving to fully regulated operations should lower earnings volatility and, over time, reduce the equity risk premium, but that re-rating only matters if management can translate a cleaner balance sheet into rate-base growth. In the near term, the divestiture can make reported earnings look softer because the company has effectively shrunk its earnings engine before the regulatory rebuild shows up.

The next 1-3 months, the stock will likely trade on guidance, not the quarter: allowed ROE, capex cadence, and whether proceeds from asset sales are being recycled into regulated investment or just used to de-lever. If the company is now a slower-growth utility with improved credit metrics, the equity could become more duration-sensitive than before — meaning higher Treasury yields would be a direct headwind even if the business is cleaner. That makes the setup more about multiple support than EPS momentum.

The contrarian view is that the headline loss may be less relevant than the structural de-risking. If the market is still pricing SR like a mixed-asset utility, there may be room for a modest multiple expansion versus higher-complexity peers; if it is already pricing in the transition, this becomes a value trap with no near-term catalyst. What would falsify the positive de-risking thesis is a weak rate-case outcome, lack of reinvestment opportunities, or guidance that shows the divestitures permanently reduced earnings power more than they improved the balance sheet.

Key Decisions for Investors

• No aggressive trade on the print alone; wait for next guidance update and capex/rate-base bridge before taking meaningful size in SR.
• If SR sells off on the loss headline and underperforms XLU by ~3-5% intraday, consider a small 3-6 month long SR / short XLU pair to express a re-rating thesis; stop if 10Y Treasury yields continue to rise or management cuts FY EPS.
• Prefer higher-growth regulated peers such as ATO or NJR over SR if the goal is utility exposure with clearer earnings momentum; SR is a cleaner balance-sheet story, not a clean growth story yet.
• Set a watch item on the next rate case and any commentary on redeploying divestiture proceeds into regulated capex; that is the real catalyst for multiple expansion over the next 6-18 months.
• If management confirms improved credit metrics and a credible rate-base expansion plan, re-evaluate SR as a long-duration utility; if not, treat the stock as a low-catalyst bond proxy with limited upside.